NYSE:LLY - Eli Lilly And Co Stock Price, Forecast & News

Eli Lilly And Co trades on the New York Stock Exchange (NYSE) under the ticker symbol "LLY."

Eli Lilly And Co announced a quarterly dividend on Monday, December 16th. Investors of record on Friday, February 14th will be paid a dividend of $0.74 per share on Tuesday, March 10th. This represents a $2.96 dividend on an annualized basis and a yield of 2.27%. The ex-dividend date of this dividend is Thursday, February 13th. This is a positive change from Eli Lilly And Co's previous quarterly dividend of $0.65. View Eli Lilly And Co's Dividend History.

Eli Lilly And Co (NYSE:LLY) released its quarterly earnings data on Thursday, January, 30th. The company reported $1.73 EPS for the quarter, topping analysts' consensus estimates of $1.52 by $0.21. The company earned $6.11 billion during the quarter, compared to the consensus estimate of $5.92 billion. Eli Lilly And Co had a return on equity of 192.27% and a net margin of 37.27%. The business's revenue for the quarter was up 8.4% on a year-over-year basis. During the same period in the previous year, the business earned $1.33 earnings per share. View Eli Lilly And Co's Earnings History.

Eli Lilly And Co is scheduled to release their next quarterly earnings announcement on Tuesday, May 5th 2020. View Earnings Estimates for Eli Lilly And Co.

Eli Lilly And Co updated its FY20 earnings guidance on Thursday, January, 30th. The company provided earnings per share guidance of $6.70-6.80 for the period, compared to the Thomson Reuters consensus estimate of $6.76. The company issued revenue guidance of $23.7-24.2 billion, compared to the consensus revenue estimate of $23.78 billion.

13 brokerages have issued 1-year target prices for Eli Lilly And Co's shares. Their forecasts range from $117.49 to $165.00. On average, they expect Eli Lilly And Co's stock price to reach $139.03 in the next twelve months. This suggests a possible upside of 6.6% from the stock's current price. View Analyst Price Targets for Eli Lilly And Co.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eli Lilly And Co in the last year. There are currently 3 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Eli Lilly And Co.

Press coverage about LLY stock has trended very negative recently, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Eli Lilly And Co earned a daily sentiment score of -3.7 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Eli Lilly And Co.

Eli Lilly And Co saw a increase in short interest in the month of January. As of January 31st, there was short interest totalling 12,980,000 shares, an increase of 14.8% from the January 15th total of 11,310,000 shares. Based on an average daily volume of 3,450,000 shares, the short-interest ratio is currently 3.8 days. Approximately 1.5% of the shares of the stock are sold short. View Eli Lilly And Co's Current Options Chain.

Some companies that are related to Eli Lilly And Co include Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Pfizer (PFE), AbbVie (ABBV), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Allergan (AGN), Mylan (MYL), Perrigo (PRGO), Jazz Pharmaceuticals (JAZZ), The Medicines (MDCO), Horizon Therapeutics (HZNP), Nektar Therapeutics (NKTR), Pacira Biosciences (PCRX) and Corcept Therapeutics (CORT).

Based on aggregate information from My MarketBeat watchlists, some companies that other Eli Lilly And Co investors own include Johnson & Johnson (JNJ), Pfizer (PFE), Merck & Co., Inc. (MRK), AT&T (T), Intel (INTC), Bristol-Myers Squibb (BMY), JPMorgan Chase & Co. (JPM), Verizon Communications (VZ), Bank of America (BAC) and Cisco Systems (CSCO).

Eli Lilly And Co's stock is owned by a number of of retail and institutional investors. Top institutional investors include Lilly Endowment Inc. (11.93%), State Street Corp (3.87%), Capital International Investors (2.71%), FMR LLC (1.48%), Geode Capital Management LLC (1.29%) and Bank of New York Mellon Corp (0.85%). Company insiders that own Eli Lilly And Co stock include Aarti S Shah, Alfonso G Zulueta, Anne E White, Christi Shaw, Daniel Skovronsky, David A Ricks, Donald A Zakrowski, Eli & Co Lilly, Enrique A Conterno, Jackson P Tai, Jeffrey N Simmons, Joshua L Smiley, Lilly Endowment Inc, Melissa S Barnes, Michael J Harrington, Myles O'neill, Stephen F Fry and Susan Mahony. View Institutional Ownership Trends for Eli Lilly And Co.

LLY stock was sold by a variety of institutional investors in the last quarter, including Lilly Endowment Inc., Investec Asset Management LTD, Alliancebernstein L.P., Janus Henderson Group PLC, LSV Asset Management, Assenagon Asset Management S.A., Massachusetts Financial Services Co. MA and AQR Capital Management LLC. Company insiders that have sold Eli Lilly And Co company stock in the last year include Aarti S Shah, Alfonso G Zulueta, Christi Shaw, Donald A Zakrowski, Lilly Endowment Inc, Melissa S Barnes, Michael J Harrington, Myles O'neill and Stephen F Fry. View Insider Buying and Selling for Eli Lilly And Co.

LLY stock was bought by a variety of institutional investors in the last quarter, including Jennison Associates LLC, Capital International Investors, FMR LLC, Amundi Pioneer Asset Management Inc., Franklin Resources Inc., CI Investments Inc., PGGM Investments and Robeco Institutional Asset Management B.V.. Company insiders that have bought Eli Lilly And Co stock in the last two years include Anne E White, Daniel Skovronsky, David A Ricks, Jackson P Tai and Joshua L Smiley. View Insider Buying and Selling for Eli Lilly And Co.

Shares of LLY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of LLY stock can currently be purchased for approximately $130.38.

Eli Lilly And Co has a market capitalization of $124.69 billion and generates $22.32 billion in revenue each year. The company earns $8.32 billion in net income (profit) each year or $6.04 on an earnings per share basis. Eli Lilly And Co employs 33,625 workers across the globe.View Additional Information About Eli Lilly And Co.

The official website for Eli Lilly And Co is http://www.lilly.com/.

Eli Lilly And Co's mailing address is LILLY CORPORATE CENTER, INDIANAPOLIS IN, 46285. The company can be reached via phone at 317-276-2000 or via email at [email protected]